Thyroid nodules are very common, and thyroid cancer is currently the fifth leading cancer
diagnosis in women. The American Thyroid Association has led the development and …

Background Molecular tests are being used increasingly as an auxiliary diagnostic tool so
as to avoid a diagnostic surgery approach for cytologically indeterminate thyroid nodules …

Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …

Aims The distinction between benign and malignant thyroid nodules has important
therapeutic implications. Our objective was to develop an assay that could classify …

Thyroid nodules affect nearly two‐thirds of the world population. Fine‐needle biopsy with
cytologic evaluation remains the diagnostic test of choice to distinguish benign from …

Context.—Approximately 15% to 30% of thyroid nodules that undergo fine-needle aspiration
are classified as cytologically indeterminate, presenting management challenges for …

Thyroid nodules are common in the adult population where a majority are benign and only
4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early …

Thyroid cancers (TC) have increasingly been detected following advances in diagnostic
methods. Risk stratification guided by refined information becomes a crucial step toward the …

Deregulation of microRNA expression has been shown to play an important role in human
malignancies. The identification of circulating-free miRNAs in biofluids a decade ago led to …

Malignant mesothelioma is a rare malignancy with a poor prognosis whose development is
related to asbestos fiber exposure. An increasing role of genetic predisposition has been …